Treace Medical Concepts Inc (TMCI): Market Cap to Revenue

Symbol and logo of brand Treace Medical Concepts Inc (TMCI)

The reliability of Treace Medical Concepts (TMCI) is based on patents and physician training for the Lapiplasty system. The price-to-sales ratio trend confirms these points, with the current level at 1.70. Treace Medical Concepts (TMCI) aims to establish the standard of care for hallux valgus through innovation. Management is currently optimizing its commercial approach to reduce expenses, which serves as a key benchmark for investors.

TMCI Treace Medical Concepts Inc P/S Multiple (07/04/2022 - 11/13/2026)

Analytical breakdowns for Treace Medical (TMCI)

- share price and consensus valuation forecast:
Price Performance Chart treace.com|TMCI - Price Target Chart
- stock exchange capitalization data:
Market Valuation Treace Medical|TMCI - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Treace Medical Concepts|TMCI - Book Capitalization|Capitalization to Book Value Ratio treace.com|TMCI - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Treace Medical Concepts|TMCI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Treace Corp|TMCI - Company Aggregate Debts|Debts to Book Capitalization Treace Medical|TMCI - Company Long-Term Debt|Company Short-Term Debt Treace Medical Concepts|Intermediate Coverage Ratio treace.com
- earnings and multiples data:
TMCI - Net Profit|Expected Net Profit Treace Medical Concepts|TMCI - Price to Earnings Ratio|Forward Price to Earnings Multiple Treace Medical Concepts Inc|TMCI - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Treace Medical|TMCI - Operating profit EBITDA|Net earnings per share for the last four quarters Treace Medical Concepts|TMCI - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months treace.com|TMCI - Earnings per share growth in current year|Expected earnings per share growth for next year Treace Medical Concepts
- issuer revenue and sales details:
TMCI - Revenue and Sales Volume|Company Expected Sales Volume treace.com|TMCI - Price-to-Revenue Ratio|Market Cap to Projected Revenue Treace Medical
General company analysis:TMCI treace.com
Core merchandise of Treace Medical Concepts

The P/S ratio relates the market capitalization of Treace Medical Concepts (TMCI) to its annual revenue, determining the cost of each unit of revenue and the level of overpayment for the asset. By analyzing the price-to-sales chart, an investor can assess whether the high loyalty of surgeons to Treace Medical Concepts (TMCI) proprietary technologies justifies the current sales premium over the long term.

Competitors of Treace Medical Concepts

BSX (bostonscientific.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Edwards Lifesciences Corporation EW|RMD - Market Cap to Revenue|OmniPod - P/S Multiple|Price to Sales Zimmer Biomet Holdings|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (Globus Medical) - P/S Multiple|TransMedics Group Inc (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion Corp AORT|P/S Multiple ENOV (Enovis Corporation)|P/S Multiple integralife.com IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (Iradimed) - Market Cap to Revenue|Embecta Health - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Diabetes Care) - P/S Multiple|Price to Sales axogeninc.com AXGN|Price-to-Revenue Ratio SI-BONE (SIBN)|Orthofix Medical (OFIX) - Price-to-Revenue Multiple|Bioventus Corp - Market Cap to Revenue|P/S Multiple OrthoPediatrics Corp KIDS|Strata Critical Medical Inc - P/S Multiple|Price-to-Revenue Coefficient carlsmed.com CARL|RxSight (RXST) - Price-to-Revenue Ratio|Price-to-Sales Ratio CLPT (ClearPoint Neuro)|Price-to-Revenue Ratio Stereotaxis Corp|Market Cap to Revenue Neuronetics, Inc (STIM)|P/S Multiple SGHT|OBIO - Price to Sales|Price-to-Revenue Ratio Anika Therapeutics, Inc. ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical, Inc. - Market Cap to Sales Volume|XTNT (xtantmedical.com) - Market Cap to Revenue|NMTC: Market Cap to Sales Volume|Price-to-Revenue Ratio Modular Medical Inc|MYO: Market Capitalization-to-Revenue Ratio|P/S Multiple COCH|VVOS - Price to Sales|P/S Multiple NVNO (enVVeno Medical)|P/S Multiple Sintx Technologies Inc SINT|Tenon Medical - P/S Multiple|ReWalk Robotics (LFWD) - Market Cap to Revenue|AMIX: P/S Multiple|Price to Sales INVO Fertility Corp (IVF)|Market Cap to Revenue BBLG|AXNX: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio BIOLASE (BIOL)|Market Cap to Revenue dynatronics.com DYNT|P/S Multiple FNA (Paragon 28)|INVO Bioscience Inc. (INVO) - Price to Sales